Deutsche Bank Ag\ Biodesix Inc Transaction History

Deutsche Bank Ag\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.32 - $2.12 $8,785 - $14,110	-6,656 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.69 - $5.81 $1,368 - $4,706	-810 Reduced 10.85%	6,656 $11,000
Q4 2021 Feb 11, 2022	BUY	$4.09 - $8.67 $1,652 - $3,502	404 Added 5.72%	7,466 $39,000
Q3 2021 Nov 04, 2021	SELL	$6.6 - $12.78 $1,511 - $2,926	-229 Reduced 3.14%	7,062 $58,000
Q2 2021 Aug 11, 2021	BUY	$12.14 - $20.35 $65,106 - $109,137	5,363 Added 278.16%	7,291 $96,000
Q1 2021 May 13, 2021	SELL	$16.87 - $31.21 $3,036 - $5,617	-180 Reduced 8.54%	1,928 $39,000
Q4 2020 Feb 16, 2021	BUY	$10.89 - $20.16 $22,956 - $42,497	2,108 New	2,108 $42,000

62.3M

2.6K

10.1K

Ticker BDSX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 39,982,000
Market Cap $55.2M
Description
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.